A thermostable mRNA vaccine against COVID-19

Zhang, Na-Na, Li, Xiao-Feng, Deng, Yong-Qiang, Zhao, Hui, Huang, Yi-Jiao, Yang, Guan, Huang, Wei-Jin, Gao, Peng +23 more·2020·Cell
DOI 10.1016/j.cell.2020.07.024

Cited by (670)

Items 501–600 of 670

  1. The fast-track development of COVID-19 vaccines
    Yousra A. El‐Maradny, Asmaa A. Ramadan, Vivek P. Chavda, Pankti C. Balar, Elrashdy M Moustafa Mohamed Redwan · 2024 · Elsevier eBooks
  2. Predicting the Degradation of COVID-19 mRNA Vaccine with Graph Convolutional Networks
    Yeshan Wang · 2021 · International Conference on Machine Learning Technologies (ICMLT)
  3. Phase transitions of liposomes: when light meets heat
    Carol S. Velez-Saboyá, Jose Rafael Guzman-Sepulveda, J. C. Ruiz‐Suárez · 2021 · Journal of Physics Condensed Matter
  4. Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world
    Min Li, Ruiwei Jiang, Enyun Wang, Dan Xiong, Tong Ou, Xiuming Zhang, Xiaowen Dou · 2022 · BMC Infectious Diseases
  5. Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing
    Yuchang Li, Mingyue Wang, Hongzhen Wu, Hui John Zhao, Lei Dong, Yunfei Li, Xiaofeng Li, Ying Margie Tang, Sen Zhang, Jing Li et al. · 2022 · Infectious Medicine
  6. COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity
    Suhad Daher‐Nashif, Rania Al-Anany, Menatalla Ali, Khadija Erradi, Elmoubasher Farag, Abdallah M. Abdallah, Mohamed M. Emara · 2022 · Archives of Virology
  7. Broad Spectrum Antiviral Therapy can Supersede Vaccination Strategy for Combating COVID-19 Pandemic
    Ashok K. Chakraborty · 2021 · Medical Journal of Clinical Trials & Case Studies
  8. Application in gene therapy and DNA/RNA vaccines
    María José Limeres, María A. Toscanini, Tomás Brito Devoto, María Florencia Ladetto, Guillermo Raul Castro, María L. Cuestas · 2022 · Elsevier eBooks
  9. Current state-of-the-art review of nanotechnology-based therapeutics for viral pandemics: Special attention to COVID-19
    Marjan Motiei, Lucian A. Lucia, Tomáš Sáha, Petr Sáha · 2023 · Nanotechnology Reviews
  10. MicroRNAs Derived from Extracellular Vesicles: Keys to Understanding SARS-CoV-2 Vaccination Response in Cancer Patients?
    Beatriz Almeida, Tânia R. Dias, Ana Luísa Teixeira, Francisca Dias, Rui Medeiros · 2023 · Cancers
  11. Cytomegalovirus-vectored COVID-19 vaccines elicit neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.2) in mice
    Jian Liu, Dabbu Kumar Jaijyan, Yanling Chen, Changcan Feng, Shaomin Yang, Zhenglong Xu, Nichun Zhan, Congming Hong, Shuxuan Li, Tong Cheng et al. · 2023 · Microbiology Spectrum
  12. The Economic, Climate Change and Public Health Edges of the Geopolitics of COVID-19: An Exploratory Bibliometric Analysis
    Jean Pierre Doussoulin, Benoît Mougenot · 2021 · IntechOpen eBooks
  13. Quantitative Assessment of the Physical Virus Titer and Purity by Ultrasensitive Flow Virometry
    Qian Niu, Ling Ma, Shaobin Zhu · 2021 · Angewandte Chemie
  14. Deep learning models for predicting RNA degradation via dual crowdsourcing
    Hannah K. Wayment-Steele, Wipapat Kladwang, Andrew M. Watkins, Do Soon Kim, Bojan Tunguz, Walter Reade, Maggie Demkin, Jonathan Romano, Roger Wellington-Oguri, John J. Nicol et al. · 2021 · PubMed
  15. Replacing Helper Lipids With Cationic Lipids Enhances mRNA Lipid Nanoparticles Stability in Solution
    Rui Chen, Letao Xu, Nan Zhang, Haitao Yu, Xing Wang, Jiali Zhai, Fiona Whelan, Phillip Elliott, Chun‐Xia Zhao · 2025 · Advanced Science
  16. Caspase inhibition improves viability and efficiency of liposomal transfection
    Tatsushi Yoshida, Kenta Yamasaki, Kenjiro Tadagaki · 2023 · Scientific Reports
  17. Nanomaterials as a Versatile Tool for COVID-19 Treatment
    Safieh Zeinali, Zeinab Moafian, Rabia Arshad, Fateme Karimi, Somayeh Zeinalilathori, Abbas Rahdar, Sonia Fathi‐karkan, Sadanand Pandey · 2024 · BioNanoScience
  18. Nanotechnology-Based Targeted Drug Delivery Systems for Cancer Treatment
    Yuxin Jin · 2025 · Theoretical and Natural Science
  19. A universal viral capsid protein based one step RNA synthesis and packaging system for rapid and efficient mRNA vaccine development
    Jiayue Su, Jinsong Zhang, Xiangning Feng, Jinsong Liu, Shan Gao, Xinrui Liu, Mingwei Yang, Zeliang Chen · 2025 · Molecular Therapy
  20. A T7 autogene-mediated DNA vaccine platform for SARS-CoV-2: Overcoming DNA vaccine limitations with enhanced spike mRNA production
    Sang Won Cho, Sang Chul Shin, Yunju Nam, Hyung Jun Ahn · 2025 · Journal of Controlled Release
  21. Current landscape with an analytical outlook: Chikungunya virus vaccine development
    Xiaoyu Zhao, Luxuan Yang, Yabo Mi, Yinying Lu, Binhuang Sun, Yi Zhang, Yu-Xuan Yang, Yu Sun, Liangjiu Zhang, Luanfeng Lin et al. · 2025 · The Innovation Medicine
  22. Emerging roles of noncoding micro RNAs and circular RNAs in bovine mastitis: Regulation, breeding, diagnosis, and therapy
    Weicheng Zong, Tianying Zhang, Bing Chen, Qinyue Lu, Xiang Cao, Kun Wang, Zhangping Yang, Zhi Chen, Yi Yang · 2022 · Frontiers in Microbiology
  23. Immunogenicity of novel DNA vaccines encoding receptor‐binding domain (RBD) dimer‐Fc fusing antigens derived from different SARS‐CoV‐2 variants of concern
    Ting Zhang, Zhirong Wang, Jiaojiao Yang, Xuemei Xu · 2023 · Journal of Medical Virology
  24. Efficacy of COVID-19 Vaccines against the Omicron Variant of SARS-CoV-2: A Review
    Kritika Srinivasan Rajsri, Meena Singh, Mana Rao · 2023 · Exploratory Research and Hypothesis in Medicine
  25. A micro-electroporation/electrophoresis-based vaccine screening system reveals the impact of vaccination orders on cross-protective immunity
    Yongyong Li, Jingshan Mo, Jing Liu, Ying Liang, Caiguanxi Deng, Zhangping Huang, Juan Jiang, Ming Liu, Xinmin Liu, Liru Shang et al. · 2023 · iScience
  26. Competitive fitness and homologous recombination of SARS‐CoV‐2 variants of concern
    Qi Chen, Si Qin, Hangyu Zhou, Yong‐Qiang Deng, Pan‐Deng Shi, Hui John Zhao, Xiaofeng Li, Xing‐Yao Huang, Yarong Wu, Yan Guo et al. · 2023 · Journal of Medical Virology
  27. Sucrose ester embedded lipid carrier for DNA delivery
    Yinan Zhao, Wanting Ma, Kexin Tian, Zhe Wang, Xingxing Fu, Qi Zuo, Yanfei Qi, Shubiao Zhang · 2024 · European Journal of Pharmaceutics and Biopharmaceutics
  28. A plasma-3D print combined in vitro platform with implications for reliable materiobiological screening
    Gerardo Hernandez‐Moreno, Vineeth M. Vijayan, Brian Halloran · 2024 · Journal of Materials Chemistry B
  29. StructmRNA a BERT based model with dual level and conditional masking for mRNA representation
    Sepideh Nahali, Leila Safari, Alireza Khanteymoori, Jimmy Xiangji Huang · 2024 · Scientific Reports
  30. How Smart Manufacturing Can Help Combat the COVID-19 Pandemic
    Yun-Siang Lin, Chao‐Min Cheng, Chen–Fu Chien · 2021 · Diagnostics
  31. A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development.
    Isak Jatoi, Jing‐Yu Fan · 2021 · PubMed
  32. Are We Paving the Way to Dig Out of the “Pandemic Hole”? A Narrative Review on SARS-CoV-2 Vaccination: From Animal Models to Human Immunization
    Giuseppe Tardiolo, Pina Brianti, Daniela Sapienza, Pia dell’Utri, Viviane Di Dio, Giuseppe Rao, Rocco Salvatore Calabrò · 2021 · Medical Sciences
  33. Vaccines against COVID-19 using nanotechnology: a literature review
    André Flores dos Santos, Alessandra Soares Ayres Fraga, Patrícia Gomes, Solange Binotto Fagan · 2021 · Disciplinarum Scientia | Naturais e Tecnológicas
  34. A Vaccine with Multiple Receptor-Binding Domain Subunit Mutations Induces Broad-Spectrum Immune Response against SARS-CoV-2 Variants of Concern
    Xuchen Hou, Huifang Xu, Yang Liu · 2022 · Vaccines
  35. Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment immunogen
    Sameer Kumar Malladi, Randhir Singh, Suman Pandey, Savitha Gayathri, Kawkab Kanjo, Shahbaz Ahmed, Mohammad Suhail Khan, Parismita Kalita, Nidhi Girish, Aditya Upadhyaya et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Recombinant Fc-fusion vaccine of RBD induced protection against SARS-CoV-2 in non-human primate and mice
    Shihui Sun, Lei He, Zhongpeng Zhao, Hongjing Gu, Xin De Fang, Tiecheng Wang, Xiaolan Yang, Shaolong Chen, Yong‐Qiang Deng, Jiangfan Li et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus
    Buyani Ndlovu, Albertha R. van Zyl, D. J. Verwoerd, Edward P. Rybicki, Inga Isabel Hitzeroth · 2025 · Vaccines
  38. Development and characterization of a bivalent mRNA vaccine targeting the Delta and Omicron variants of SARS-CoV-2
    Xiao-Chuan Xiong, Nana Zhang, Mei Wu, Tian-Shu Cao, Kao Deng, Zu-Xing Wang, Yong‐Qiang Deng, Cheng‐Feng Qin, Qing Ye · 2025 · Human Vaccines & Immunotherapeutics
  39. Lipid nanoparticle-mediated mRNA delivery system into preimplantation embryos
    Chihiro Emori, Hiroki Tanaka, Tatsuya Nakagawa, Hidetaka Akita, Masahito Ikawa · 2025 · Biology of Reproduction
  40. Recent advances in LNP-mRNA vaccines
    Benjamin J. Redenti, Yichen Zhong, Changyue Yu, Yizhou Dong · 2026 · Colloids and Surfaces B Biointerfaces
  41. Applications of advances in mRNA-based platforms as therapeutics and diagnostics in reproductive technologies
    Wjdan S. Bafleh, Haia M. R. Abdulsamad, Sally M. Al-Qaraghuli, Riwa Y. El Khatib, Rawdah Taha Elbahrawi, Azhar Mohamud Abdukadir, Shaima M. Alsawae, Zakia Dimassi, Hamdan Hamdan, Junaid Kashir · 2023 · Frontiers in Cell and Developmental Biology
  42. The discovery and development of mRNA vaccines for the prevention of SARS-CoV-2 infection
    Vivian Weiwen Xue, Sze Chuen Cesar Wong, Bo Li, William Chi Shing Cho · 2023 · Expert Opinion on Drug Discovery
  43. Phytochemical-loaded Nanoparticles in COVID-19 Management
    Suneetha Vuppu, Toshika Mishra, Shatakshi Mishra, Bala Kumar Stany, Anushka Das · 2023 · Natural Resources for Human Health
  44. Recent Advances in mRNA Vaccine Development
    Aga AM · 2023 · Open Access Journal of Microbiology & Biotechnology
  45. Microfluidic methods for liposome formation
    Calvin C.L. Cheung, Wafa’ T. Al-Jamal · 2024 · Elsevier eBooks
  46. Nanotechnology based materials and inventions to fight against COVID-19: recent progress in the development of robust diagnostics, surveillance tools, therapeutics and vaccines
    Shweta Kumar, Hema Singh, Mahendra Kumar Verma · 2024 · Health and Technology
  47. Spleen Targeting Nucleic Acid Delivery Vector Based on Metal–Organic Frameworks
    Yiming Wang, Chen Wang, Yuan Lu · 2024 · ACS Applied Materials & Interfaces
  48. Protection efficacy of mRNA-based SARS-CoV-2 variant vaccine in non-human primates
    Dongrong Yi, Yongxin Zhang, Jing Wang, Qian Liu, Ling Ma, Quanjie Li, Saisai Guo, Ruifang Zheng, Xiaoyu Li, Xingong Li et al. · 2024 · Acta Pharmaceutica Sinica B
  49. Immunobiology and immunotherapy of COVID-19
    Kenneth H. Lundstrom · 2025 · Progress in molecular biology and translational science
  50. Chimeric receptor-binding domain vaccine design and sequential immunization enhanced broadly neutralizing antibody responses against COVID-19
    Xiao Yang, Xin Tang, Ying Sun, Hualong Xi, Wei Peng, Yan Lu, Wenjing Teng, Yang Zang, Chunlai Jiang · 2025 · Frontiers in Immunology
  51. Impact of B18R-Encoding Messenger Ribonucleic Acid Co-Delivery on Neutralizing Antibody Production in Self-Amplifying Messenger Ribonucleic Acid Vaccines
    Yutao Wang, Lei Li, Min Liang, Gan Liu, Yinying Lu · 2025 · Vaccines
  52. Progress and prospects of therapeutic vaccines for cardiovascular diseases
    Zhihua Qiu, XiaJun HU, YanZhao ZHOU, HaiLang WU, Jiayu Zheng, YingXuan WANG, Yuhua Liao · 2022 · Scientia Sinica Vitae
  53. Baculovirus displaying SARS-CoV-2 spike RBD promotes neutralizing antibody production in a mouse model
    Mohamed A. Wahba, Dina Mofed, Doaa Ahmad Ghareeb · 2023 · Journal of Genetic Engineering and Biotechnology
  54. Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19
    M. Ramesh, Krishnan Anand, Mohd Shahbaaz · 2021 · Frontiers in Molecular Biosciences
  55. Rapid development of SARS-CoV-2 receptor binding domain-conjugated nanoparticle vaccine candidate
    Yinfeng Kang, Cong Sun, Zhen Zhuang, Run-Yu Yuan, Qingbing Zheng, Jiangping Li, Pingping Zhou, Xinchun Chen, Xiao Zhang, Xiaohui Yu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  56. Recombinant Fc-fusion vaccine of RBD induced protection against SARS-CoV-2 in non-human primate and mice
    Shihui Sun, Lei He, Zhongpeng Zhao et al. · 2021 · Research Square
  57. The recombinant subunit vaccine RBD-Fc, consisting of SARS-CoV-2 RBD and human IgG Fc as an immunopotentiator, elicits robust neutralizing antibody responses against SARS-CoV-2 infection
    Zezhong Liu, Wei Xu, Shuai Xia, Chenjian Gu, Xinling Wang, Qian Wang, Jie Zhou, Yan‐Ling Wu, Xia Cai, Di Qu et al. · 2020 · Research Square
  58. Impact of Prior Infection on Protection and Transmission of SARS-CoV-2 in Golden Hamsters
    Cheng Zhang, Zhendong Guo, Nan Li, Huan Yong Cui, Keyin Meng, Lina Liu, Li Zhao, Shanshan Zhang, Cheng‐Feng Qin, Juxiang Liu et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Structural Characterization of mRNA Lipid Nanoparticles in the Presence of Intrinsic Drug-free Lipid Nanoparticles
    Xiaoxia Chen, Yongfeng Ye, Mengrong Li, Taisen Zuo, Zhenhua Xie, Yubin Ke, He Cheng, Liang Hong, Zhuo Liu · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Immunogenicity and Protective Efficacy of a SARS-CoV-2 mRNA Vaccine Encoding Secreted Non-Stabilized Spike Protein in Mice
    Prompetchara, Eakachai, Ketloy, Chutitorn, Alameh, Mohamad-Gabriel, Tarakhet, Kittipan, Kaewpang, Papatsara, Yostrerat, Nongnaphat, Pitakpolrat, Patrawadee, Buranapraditkun, Supranee, Manopwisedcharoen, Suwimon, Thitithanyanont, Arunee et al. · 2022
  61. COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects
    Shen Wang, Ling Li, Fei-Hu Yan, Yu-Wei Gao, Song-Tao Yang, X. Xia · 2021 · Vaccines
  62. The Multifareous role of Nanomedicine in healthcare
    Keerthi Somashekar, Divya Badoni, Sneh Gautam · 2022 · Journal of Scientific and Innovative Research
  63. Interleukin-35 mRNA therapy for influenza virus-induced pneumonia in mice
    Yanyan Li, Yuqin Liao, Yiqi Miao, Changxiao Yu, Jinrong Long, Jiayu Wu, Jun Zuo, Zhen Zhang, Wei Dou, Xin Wang et al. · 2025 · European Journal of Pharmacology
  64. Next-Generation Nanoparticle-Enabled mRNA Vaccines in the Treatment of COVID-19
    Eknath B. Kole, Krishna Jadhav, Raghuraj Singh, Rahul Kumar Verma, Aniruddha Chatterjee, Jitendra Naik · 2025 · Critical Reviews in Therapeutic Drug Carrier Systems
  65. A Poly-Lysine-Based RBD Mucosal Vaccine Induces Potent Antibody Responses in Mice
    Huifang Xu, Han Wang, Peng Sun, Tiantian Wang, Bin Zhang, Xuchen Hou, Jun Wu, Bo Liu · 2025 · Vaccines
  66. Evaluating cell cycle- and autophagy-associated cellular accumulation of lipid-based nanoparticles
    Yisha Wang, Gan Luo, Haiyang Wang, Yue Zheng, Xiao Xu, Wenbin Zhou, J.Z. Lin, B.Y. Chen, Yarong Guo, Yifeng Jin et al. · 2025 · Nature Communications
  67. Adenovirus-Based Single-Dose Vaccines for SARS-CoV-2: A Review
    Vivek P. Chavda, Anita A. Mehta, Hajra Zafar, Faisal Raza, Ana Cláudia Paiva‐Santos, Pankti C. Balar, Vasso Apostolopoulos, Lalitkumar K. Vora · 2025 · Frontiers in Bioscience-Landmark
  68. A safe and broad-spectrum SARS-CoV-2 mRNA vaccine with a new delivery system for in-situ expression
    Weiyi Yu, Xianying Chen, Qiubing Chen, Peixuan Chen, Naizhang Liu, Yingjian Li, Xue Tan, Qiuhan Zhang, Yan Rao, Ming Sen Guo et al. · 2025 · Virologica Sinica
  69. Covalent conjugation of TLR9 agonists to phospholipids enhances mRNA-LNP delivery efficiency and dendritic cell cross-priming
    Wanting Ji, Keer Zhu, Yanyan Zhou, Haomin Yan, Jiani Wei, Ying Jian Zhu, Sheng Li, Yuqi Hong, Jinyao Dai, Shaohua Dong et al. · 2026 · Journal of Nanobiotechnology
  70. Intra-tracheal photoacoustic endoscopy for in vivo tracking of inhaled nano-adjuvants
    Xiaowei Chen, Chaohao Liang, Fengbing He · 2025 · APL Photonics
  71. Therapeutic potential of ISG20 in attenuating podocyte injury via inhibition of ferroptosis
    Di Zhou, Xinyi Chen, Meng Jia, Xiaoxiao Liu, Lingzhi Huang, Yongsheng Xie, Liang Li, Yi Fu, Yubin Feng, Zhaoyi Yang et al. · 2025 · Molecular Therapy — Nucleic Acids
  72. Comparative evaluation of two platforms delivering RSV mRNA vaccines expressing modified extracellular domain of G glycoprotein in mice
    Ruiwen Han, Aiyi Zhang, Yujie Jiang, Siyu Yin, Tangqi Wang, Xinwei Gao, Yao Deng, Yu Li, Wenjie Tan · 2026 · International Immunopharmacology
  73. Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection
    Lingyan Cui, Sibo Zhang, Yarong Zeng, Limin Zhang, Min Lin, Minqing Hong, Huiqing Chen, Hong Wang, Wenhui Xue, Miaolin Lan et al. · 2026 · ACS Nano
  74. Confronting the known unknown: historical lessons and future strategies for Disease X
    Y H Xiang, Guangxi Sun, Pinpin Xiang, Jiangtao Hu, Lvbo Tian, Qin Zhang, Junxian Wang, Chunbao Xie · 2026 · Frontiers in Public Health
  75. Engineered circular RNA compatible with complete nucleoside modification and rolling circle translation through a Cap-independent translation enhancer
    Xinyue Wang, Qian Pan, Jie Yin, Haomeng Kou, Xinyuan Liao, Chi Zhang, Yanyan Wang, Shengnan She, Ligaoyue Zhang, Wanjia Wang et al. · 2026 · Nature Biomedical Engineering
  76. Applications of Spray-Dried Vaccines
    Cordin Arpagaus · 2023 · Springer eBooks
  77. Rational design of an EDIII mRNA vaccine candidate against Zika virus
    Ying Tian, Mei Wu, Kai Li, Chao Hui ZHOU, Rongrong Zhang, Hangyu Zhou, Qing Ye, Cheng‐Feng Qin, Shenghai Huang, Xiao-Feng Li · 2023 · Chinese Science Bulletin (Chinese Version)
  78. Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open‐label, and single‐arm Phase 1 study
    Suad Hannawi, Rong‐Rong Zhang, Alaa Abuquta, Linda Saf Eldin, Aala Hassan, Ahmad Alamadi, Tasmiah Hossain, Mohamed Mostafa, Yasser Ghoneim, Jennifer Solo et al. · 2023 · Clinical and Translational Medicine
  79. RNA therapeutics for infectious diseases
    Le Minh Tu Phan; Phan Le Minh Tu, Thi Thuy Duong Pham, Van Thai Than · 2024 · Progress in molecular biology and translational science
  80. Research Progress of Nanomaterials for Prevention, Diagnosis, and Treatment of SARS-CoV-2
    Yachan Feng, Haojie Zhang, Jiangtao Shao, Xiaolei Zhou, Yu Fu, Chao Du, Xueling Guo, Yingze Wang · 2024 · BioNanoScience
  81. Nobel Prize in physiology or medicine 2023: Development of mRNA therapeutics that paved the path of formulation of COVID-19 vaccine
    Neetesh Mandal · 2024 · Journal of Hematology and Allied Sciences
  82. Potential use of CRISPR/Cas13 system for vaccine development against various RNA-viral infections
    Barsha Mohanty, Rakeeb Ahmad Mir, Ankita Priyadarshini, Kaisar Ahmad Bhat, Shirin Barati, Elmira Roshani Asl, Jane Ru Choi, Yousef Rasmi · 2024 · Future Virology
  83. The Current Progress in the Quest for Vaccines Against the Semliki Forest Virus Complex
    Dorothy Hui Juan Cheong, Bowen Yi, Yi Hao Wong, Justin Jang Hann Chu · 2025 · Medicinal Research Reviews
  84. Climatological and social fallacies about COVID-19 pandemic
    Ambar Farooq, Uttam Kumar, Junaite Bin Gais Uddin, Muhammad Haroon U. Rashid, Matoor Mohsin Gilani, Taimoor Hassan Farooq, Awais Shakoor, Matloob Ahmad · 2021 · Environmental Sustainability
  85. The effect of RNA and non-RNA vaccines in variants of Covid-19: A narrative review
    Maryam Rahmannia, Shahryar Rajai Firouz Abadi, Ahad Hasan Syed Hasani, F. Khanali, Fatemeh Vosoughian, Roya Mirzaei, H. Esmaeili · 2021 · Pakistan Journal of Medical & Health Sciences
  86. pDNA and mRNA vaccines
    Kanwal Gill, Leanne Minall, Aslin Rodríguez Nassif · 2021 · Elsevier eBooks
  87. Particulate vaccines against SARS-CoV-2
    Mariano J. García-Soto, Susan Farfán-Castro, Alejandra Wong-Arce, Andrea Romero‐Maldonado, Omar González‐Ortega, Sergio Rosales‐Mendoza · 2021 · Elsevier eBooks
  88. mRNA疗法的研究进展与挑战
    Jiayan Fu, Shuo Feng, Binhe Du, Haiyang Dong, Jinzhong Lin, Jin Yongfeng · 2021 · Scientia Sinica Vitae
  89. Die vierte Welt(wirtschafts)krise – Teufliche Regelkreise zwischen Ökonomie, Pandemie und Politik
    E. W. Udo Küppers · 2022 · Springer eBooks
  90. Molecular Docking and Pharmacokinetic Studies of Aquillochin and Grewin as SARS-CoV-2 Mpro Inhibitors
    Adnan Çetin · 2022 · Drug Delivery Letters
  91. Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice
    Qiong Zhang, Shashi Kant Tiwari, Jing A. Wen, Shaobo Wang, Lingling Wang, Wanyu Li, Lingzhi Zhang, Stephen Rawling, Yong Cheng, Jesse V. Jokerst et al. · 2024 · PLoS ONE
  92. Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccine
    Yangtao Wu, Xiaofen Huang, Lunzhi Yuan, Shaojuan Wang, Yali Zhang, Hualong Xiong, Rirong Chen, Jian Ma, Ruoyao Qi, Meifeng Nie et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  93. A recombinant SARS-CoV-2 RBD antigen expressed in insect cells elicits immunogenicity and confirms safety in animal models
    Ricardo Choque-Guevara, Astrid Poma-Acevedo, Ricardo Montesinos et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  94. Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection
    Alexandra C. Willcox, Kevin Sung, Meghan E. Garrett, Jared Galloway, Megan A. O’Connor, Jesse H. Erasmus, Jennifer K. Logue, David W. Hawman, Helen Y. Chu, Kim J. Hasenkrug et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Circular RNAs may embed pieces of real-world sensory information into an episodic memory
    Arun Asok · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Rationally designed multimeric nanovaccines using icosahedral DNA origami for molecularly controlled display of SARS-CoV-2 receptor binding domain
    Qingqing Feng, Keman Cheng, Lizhuo Zhang et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  97. A mpox quadrivalent mRNA vaccine protects mice from a lethal vaccinia virus challenge
    Sandra Chiu, Entao Li, Qizan Gong et al. · 2023 · Research Square
  98. Advances in Nanoparticle-Enhanced Vaccine Strategies: Towards a Universal Protection Against Influenza B Viruses
    Shounak Row, Kunal D. Kondhare · 2024 · Preprints.org
  99. Modified or Unmodified mRNA Vaccines? – The Biochemistry of Pseudouridine and mRNA Pseudouridylation
    Pedro Morais, Yi‐Tao Yu · 2024 · Wiley eBooks
  100. Design and Development of mRNA Vaccines to Combat the COVID ‐19 Pandemic
    István Tombácz · 2024 · Wiley eBooks